Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soufiane Nassiri

Showing results (1-10 of 6) with videos related to

Pageof 1
Sort By:
Open Heart|May 8, 2024
Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysisSoufiane Nassiri, Arno A Van de Bovenkamp, Sharon Remmelzwaal, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 4, 2025
Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohortsXinyu Li, Anouk Achten, Soufiane Nassiri, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2025
Long-term hemodynamic responses and reverse remodeling after pharmacotherapy in HFpEF versus HFrEF: a systematic review and meta-analysisArno A van de Bovenkamp, Soufiane Nassiri, Adrianus J Bakermans, et al.
European Journal of Heart Failure|July 28, 2025
Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trialSoufiane Nassiri, Geert H D Voordes, Loek van Heerebeek, et al.
European Journal of Heart Failure|May 18, 2026
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trialArno A van de Bovenkamp, Soufiane Nassiri, Frances S de Man, et al.
Cardiovascular Drugs and Therapy|April 14, 2025
Geranylgeranylacetone as Prevention for Postoperative Atrial Fibrillation (GENIALITY)Kennedy S Ramos, Soufiane Nassiri, Leonoor F J Wijdeveld, et al.
Pageof 1

Showing results (1-10 of 6) with videos related to

Sort By:
Pageof 1
Open Heart|May 8, 2024
Effects of trimetazidine on heart failure with reduced ejection fraction and associated clinical outcomes: a systematic review and meta-analysisSoufiane Nassiri, Arno A Van de Bovenkamp, Sharon Remmelzwaal, et al.
Netherlands Heart Journal : Monthly Journal of the Netherlands Society of Cardiology and the Netherlands Heart Foundation|November 4, 2025
Sex-specific performance of clinical diagnostic algorithms for HFpEF across two independent cohortsXinyu Li, Anouk Achten, Soufiane Nassiri, et al.
American Journal of Physiology. Heart and Circulatory Physiology|January 18, 2025
Long-term hemodynamic responses and reverse remodeling after pharmacotherapy in HFpEF versus HFrEF: a systematic review and meta-analysisArno A van de Bovenkamp, Soufiane Nassiri, Adrianus J Bakermans, et al.
European Journal of Heart Failure|July 28, 2025
Effects of geranylgeranylacetone on diastolic and microvascular function in patients with heart failure with a preserved ejection fraction: A phase 2, randomized, placebo-controlled, crossover trialSoufiane Nassiri, Geert H D Voordes, Loek van Heerebeek, et al.
European Journal of Heart Failure|May 18, 2026
Intravenous IRON supplementation in Heart Failure with Preserved Ejection Fraction and iron deficiency (IRON-HFpEF): a comprehensive phase II multicentre placebo-controlled randomised clinical trialArno A van de Bovenkamp, Soufiane Nassiri, Frances S de Man, et al.
Cardiovascular Drugs and Therapy|April 14, 2025
Geranylgeranylacetone as Prevention for Postoperative Atrial Fibrillation (GENIALITY)Kennedy S Ramos, Soufiane Nassiri, Leonoor F J Wijdeveld, et al.
Pageof 1